Fundraising Fox
Phlox Therapeutics
Naarden, NL · Founded 2022 · 8 employees on LinkedIn · 11 known investors
Find your way into Phlox Therapeutics
Sign up to see every warm intro you have to Phlox Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phlox Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
Investors · 11
How we know: ROM Utrecht Region's portfolio page · the company's own site · siliconcanals.com · the VCSheet dataset · Not right? Tell us
How we know: UvA Ventures Holding's portfolio page · Not right? Tell us
How we know: phloxtherapeutics.com · Not right? Tell us
Also in the syndicate · 8
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingDec 2024
Amsterdam UMC Venture Holding, FIRST fund, ROM Utrecht Region, Utrecht Health Seed Fund (USHF)
Source ↗ - Undisclosed amountseed financing roundMay 2023
AMC Ventures Holding, FIRST, managed by BioGeneration Ventures (BGV), Innovation Fund Noord Holland (INH), Utrecht Health Seed Fund (UHSF)
Source ↗ - Undisclosed amountseed investment roundMay 2022 · 2 sources
FIRST fund, managed by BioGeneration Ventures (BGV)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Phlox Therapeutics do?
- Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
- Who are Phlox Therapeutics's investors?
- Phlox Therapeutics's investors include ROM Utrecht Region, UvA Ventures Holding, BGV.
- Where is Phlox Therapeutics headquartered?
- Phlox Therapeutics is headquartered in Naarden, NL.